A blind randomized trial was carried out to evaluate the effect of autologous BM-MSCs transplantation (the mean number of injected cells 2.75 × 106/kg) in 20 T1DM patients (including 10 controls who received insulin therapy alone). Here, INS is linked to type 1 diabetes mellitus.